Monday, May 11, 2009

Another study about clot-busting developments

Not long ago, researchers from Johns Hopkins University released a study about the use of an aggressive clot-busting treatment for stroke patients.

New results from a multicenter study led by Johns Hopkins show that patients who got an experimental clot-busting treatment for a particularly lethal form of stroke were not only dramatically more likely to survive but also continued to shed lingering disabilities six months later. The findings, announced Feb. 19 at the International Stroke Conference in San Diego, are likely to build support for the use of tissue plasminogen activator, or tPA, in patients with intracerebral hemorrhage, a treatment-resistant form of stroke marked by brain bleeding.

There's been some disagreement about tPA, so new studies are important to get some clear answers.

No comments: